NGM Biopharmaceuticals' Series B Round

NGM Biopharmaceuticals raised a round of funding on March 15, 2010.

NGM Biopharmaceuticals is a drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity and other cardio-metabolic diseases. The Company …

Articles about NGM Biopharmaceuticals' Series B Round: